Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
In my opinon, their automotive division at this moment is not looking good. Their new facility at Batu Kawan will be ready in the early next year to cater for the demand coming from their medical division. It is a stock for the long term.
They already mentioned that their Q1 in FY2024 wouldn't be looking good. Let's see whether they can deliver in the 2H2024 or not.
I'm in for the long term prosperity and I trust the chairman Chuah will lead the company to hit 1b revenue in 2025.
This company is very good, their chairman is a person with very long term view.
To be honest, their backend tester for SiC saved their a** last year. They still managed to strive even though majority of the ATE companies sh*t in their pants last year.
This year, market will witness them to transition from a company that is operating in a very cyclical industry, to a company that is operating in a well balanced set of industries.
Market hasn't realize and price in their exposure in the medical automation industry. Keep in mind that this is a recession proof industry with high growth in the future.
As mentioned in their annual report, they will continue to grow in this financial year.
This is a no-brainer investment with low risk and moderate return.
Market is very nice towards good ATE companies like Vitrox, Greatec and Penta.
Although the upcoming quarter might not be looking good, I truly believe that all the institution inside will support the share price.
Besides that it went down from RM5++ to the current share price, any disappointment in the upcoming QR has been priced in.
